Mylan NL CEO Heather Bresch holds EpiPens during a House Oversight and Government Reform Committee hearing on the Rising Price of EpiPens at the... ...http://www.businessinsider.in/EpiPen-is-going-to-have-some-competition/articleshow/55071505.cms
GlobeNewswire 2016-10-26 -- Preliminary data from the dose-escalation part of an ongoing Phase I trial in elderly and heavily pretreated... ...http://www.bizwireexpress.com/showstoryGNW.php?storyid=140972
ROCKVILLE, Md., Oct. 26, 2016 /PRNewswire-USNewswire/ -- Expert System (EXSY.MI), the leader in cognitive technology for the effective management... ...http://www.itnewsonline.com/prnewswire/Acciona-selects-Expert-System-to-support-its-Innovation-Division/459094
By Deena Beasley (Reuters) - Privately held drugmaker Kaleo Inc announced on Wednesday plans for a U.S. relaunch of its Auvi-Q injector for... ...https://in.news.yahoo.com/epipen-rival-plans-return-u-market-first-half-115951643--finance.html
Lexicon reports positive top-line results in phase 2 dose-ranging study for sotagliflozin in patients with type 1 diabetes. Lexicon... ...http://www.pharmaceutical-tech.com/news/lexicon-reports-positive-mid-stage-data-on-diabetes-drug
Radisson Blu Hotel New Delhi Paschim...